Open AccessOwn experience in the treatment of primary refractory Hodgkin's lymphoma. Case report
Author(s) -
E. E. Gushchina,
М. А. Vernyuk,
А. М. Червонцева,
И. В. Черкашина,
L. S. Khayrullina,
В. В. Лунин,
А. А. Феденко
Publication year - 2022
Publication title -
journal of modern oncology
Language(s) - English
Resource type - Journals
eISSN - 1815-1442
pISSN - 1815-1434
DOI - 10.26442/18151434.2022.2.201518
Subject(s) - brentuximab vedotin , bendamustine , medicine , refractory (planetary science) , oncology , salvage therapy , lymphoma , first line treatment , hematopoietic stem cell transplantation , disease , surgery , hodgkin lymphoma , chemotherapy , rituximab , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom